Jason B. Daly Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Jason B. Daly is EVP, Chief Legal Officer of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 10,606 shares of AMRX, which is worth approximately $95,666. The most recent transaction as insider was on Aug 12, 2025, when has been sold 22,000 shares (Class A Common Stock) at a price of $9.05 per share, resulting in proceeds of $199,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.6K

67.47% 3M change

81.5% 12M change

Total Value Held $95,666

Jason B. Daly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2025	SELL Open market or private sale	$199,100 $9.05 p/Share	22,000 Reduced 67.47%	10,606 Class A Common Stock
Mar 06 2025	SELL Open market or private sale	$409,751 $8.73 p/Share	46,936 Reduced 59.01%	32,606 Class A Common Stock
Mar 05 2025	SELL Open market or private sale	$382,408 $8.88 p/Share	43,064 Reduced 35.12%	79,542 Class A Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$137,718 $8.84 p/Share	15,579 Reduced 11.27%	122,606 Class A Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	35,879 Added 20.61%	138,185 Class A Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$430,510 $8.76 p/Share	49,145 Reduced 32.45%	102,306 Class A Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	-	151,451 Added 53.12%	133,644 Class A Common Stock
Nov 21 2024	SELL Open market or private sale	$114,786 $8.4 p/Share	13,665 Reduced 100.0%	0 Class A Common Stock
Nov 15 2024	SELL Open market or private sale	$375,886 $8.61 p/Share	43,657 Reduced 76.16%	13,665 Class A Common Stock
Mar 03 2024	SELL Payment of exercise price or tax liability	$98,624 $5.47 p/Share	18,030 Reduced 23.93%	57,322 Class A Common Stock
Mar 03 2024	BUY Exercise of conversion of derivative security	-	60,871 Added 47.17%	68,186 Class A Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$15,674 $1.92 p/Share	8,164 Reduced 36.05%	14,481 Class A Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	22,645 Added 50.0%	22,645 Class A Common Stock

JBD

Jason B. Daly

EVP, Chief Legal Officer

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account